State Street Corp Rhythm Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 1,993,166 shares of RYTM stock, worth $112 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,993,166

Previous 2,003,882 0.53%

Holding current value

$112 Million

Previous $82.3 Million 26.91%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.81 - $55.0 $437,319 - $589,380	-10,716 Reduced 0.53%	1,993,166 $104 Million
Q2 2024 Aug 14, 2024	SELL	$35.41 - $44.37 $35.8 Million - $44.8 Million	-1,009,956 Reduced 33.51%	2,003,882 $82.3 Million
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $31.6 Million - $42.4 Million	807,820 Added 36.62%	3,013,838 $131 Million
Q4 2023 Feb 14, 2024	SELL	$21.39 - $49.64 $3.42 Million - $7.93 Million	-159,838 Reduced 6.76%	2,206,018 $101 Million
Q3 2023 Nov 14, 2023	SELL	$15.81 - $27.8 $14.3 Million - $25.1 Million	-901,569 Reduced 27.59%	2,365,856 $54.2 Million
Q2 2023 Aug 14, 2023	BUY	$16.32 - $21.15 $10.7 Million - $13.9 Million	655,237 Added 25.08%	3,267,425 $53.9 Million
Q1 2023 May 15, 2023	SELL	$16.88 - $34.24 $9.6 Million - $19.5 Million	-568,510 Reduced 17.87%	2,612,188 $46.6 Million
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $1.17 Million - $1.6 Million	52,793 Added 1.69%	3,180,698 $92.6 Million
Q3 2022 Nov 15, 2022	BUY	$4.3 - $30.85 $12.4 Million - $88.8 Million	2,876,846 Added 1145.88%	3,127,905 $76.6 Million
Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $1.75 Million - $6.86 Million	-560,124 Reduced 69.05%	251,059 $1.04 Million
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $6.87 Million - $13.7 Million	-1,119,907 Reduced 57.99%	811,183 $9.35 Million
Q4 2021 Feb 14, 2022	SELL	$8.62 - $13.9 $2.53 Million - $4.08 Million	-293,627 Reduced 13.2%	1,931,090 $19.3 Million
Q3 2021 Nov 15, 2021	BUY	$11.68 - $20.72 $532,958 - $945,453	45,630 Added 2.09%	2,224,717 $29.1 Million
Q2 2021 Aug 16, 2021	SELL	$18.52 - $22.55 $4.86 Million - $5.91 Million	-262,293 Reduced 10.74%	2,179,087 $42.7 Million
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $23.5 Million - $45.9 Million	1,162,261 Added 90.86%	2,441,380 $51.9 Million
Q4 2020 Feb 16, 2021	BUY	$21.17 - $32.61 $8.37 Million - $12.9 Million	395,139 Added 44.7%	1,279,119 $38 Million
Q3 2020 Nov 10, 2020	SELL	$18.13 - $30.61 $4.58 Million - $7.73 Million	-252,512 Reduced 22.22%	883,980 $19.2 Million
Q2 2020 Aug 14, 2020	BUY	$14.41 - $25.35 $2.29 Million - $4.03 Million	158,791 Added 16.24%	1,136,492 $25.3 Million
Q1 2020 May 11, 2020	BUY	$13.16 - $22.9 $12.9 Million - $22.4 Million	977,701 New	977,701 $14.9 Million

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Rhythm Pharmaceuticals, Inc. Transaction History